- Abstract
- Core Tip
- Full Article (PDF)
- Full Article with Cover (PDF)
- Full Article (XML)
- Full Article (HTML)
- Audio
- PubMed Central
- PubMed
- CrossRef
- Google Scholar
- Similar Articles (260)
- Timeline of Article Publication (2)
- Authors Evaluation (3)
- Article Quality Tracking (0)
- Reference Citation Analysis (1)
Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5249)
All Articles published online
|
Publishing Process of This Article
|
Feb 28, 2024 (publication date) through May 3, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Qiu XX, Cheng SL, Liu YH, Li Y, Zhang R, Li NN, Li Z. Fecal microbiota transplantation for treatment of non-alcoholic fatty liver disease: Mechanism, clinical evidence, and prospect. World J Gastroenterol 2024; 30(8): 833-842 [PMID: 38516241 DOI: 10.3748/wjg.v30.i8.833] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v30/i8/833.htm |
| Number | Citing Articles |
| 1 |
Giada Marroncini, Laura Naldi, Serena Martinelli, Amedeo Amedei. Gut–Liver–Pancreas Axis Crosstalk in Health and Disease: From the Role of Microbial Metabolites to Innovative Microbiota Manipulating Strategies. Biomedicines 2024; 12(7): 1398 doi: 10.3390/biomedicines12071398
|
| 2 |
Samradhi Singh, Mona Kriti, Roberto Catanzaro, Francesco Marotta, Mustafa Malvi, Ajay Jain, Vinod Verma, Ravinder Nagpal, Rajnarayan Tiwari, Manoj Kumar. Deciphering the Gut–Liver Axis: A Comprehensive Scientific Review of Non-Alcoholic Fatty Liver Disease. Livers 2024; 4(3): 435 doi: 10.3390/livers4030032
|
| 3 |
Jiawang Wang, Zhongyu Wang, Yao Yu, Si Cheng, Jianping Wu. Advances in research on metabolic dysfunction-associated steatotic liver disease. Life Sciences 2025; 362: 123362 doi: 10.1016/j.lfs.2024.123362
|
| 4 |
Mahmoud Zhra, Muhammad Affan Elahi, Aamira Tariq, Ahmed Abu-Zaid, Ahmed Yaqinuddin. Sirtuins and Gut Microbiota: Dynamics in Health and a Journey from Metabolic Dysfunction to Hepatocellular Carcinoma. Cells 2025; 14(6): 466 doi: 10.3390/cells14060466
|
| 5 |
Qing Zhou, Cuiting Yang, Mingyue Jia, Qingsong Qu, Xinhui Peng, Weishuo Ren, Guoqing Li, Yueyang Xie, Bingxuan Li, Xinyuan Shi. Gut Microbiota-Targeted Intervention of Hyperlipidemia Using Monascus-Fermented Ginseng. Pharmaceuticals 2025; 18(5): 661 doi: 10.3390/ph18050661
|
| 6 |
DAI ISHIKAWA, XIAOCHEN ZHANG, AKIHITO NAGAHARA. Current Applications and Future Prospects of Fecal Microbiota Transplantation. Juntendo Medical Journal 2025; 71(2): 68 doi: 10.14789/ejmj.JMJ24-0045-R
|
| 7 |
Bernd Schnabl, Christopher J. Damman, Rotonya M. Carr. Metabolic dysfunction–associated steatotic liver disease and the gut microbiome: pathogenic insights and therapeutic innovations. Journal of Clinical Investigation 2025; 135(7) doi: 10.1172/JCI186423
|